Does RUXOLITINIB Cause Aspergillus infection? 129 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Aspergillus infection have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.2% of all adverse event reports for RUXOLITINIB.
129
Reports of Aspergillus infection with RUXOLITINIB
0.2%
of all RUXOLITINIB reports
45
Deaths
72
Hospitalizations
How Dangerous Is Aspergillus infection From RUXOLITINIB?
Of the 129 reports, 45 (34.9%) resulted in death, 72 (55.8%) required hospitalization, and 15 (11.6%) were considered life-threatening.
Is Aspergillus infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 129 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Aspergillus infection?
PREDNISONE (1,231)
TACROLIMUS (1,099)
RITUXIMAB (952)
MYCOPHENOLATE MOFETIL (888)
METHOTREXATE (828)
METHYLPREDNISOLONE (788)
DEXAMETHASONE (785)
CYCLOPHOSPHAMIDE (733)
ETOPOSIDE (676)
PREDNISOLONE (667)
Which RUXOLITINIB Alternatives Have Lower Aspergillus infection Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE